Exxonmobil Investment Management Inc. TX cut its position in shares of Clorox Co. (NYSE:CLX) by 1.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 33,058 shares of the company’s stock after selling 422 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Clorox were worth $4,138,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also modified their holdings of the company. Valley National Advisers Inc. raised its position in shares of Clorox by 0.6% in the second quarter. Valley National Advisers Inc. now owns 845 shares of the company’s stock worth $117,000 after buying an additional 5 shares during the period. Checchi Capital Advisers LLC raised its position in shares of Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock worth $113,000 after buying an additional 8 shares during the period. Wetherby Asset Management Inc. raised its position in shares of Clorox by 1.0% in the second quarter. Wetherby Asset Management Inc. now owns 2,408 shares of the company’s stock worth $333,000 after buying an additional 25 shares during the period. CLS Investments LLC raised its position in shares of Clorox by 1.8% in the second quarter. CLS Investments LLC now owns 1,828 shares of the company’s stock worth $253,000 after buying an additional 33 shares during the period. Finally, Keel Point LLC raised its position in shares of Clorox by 0.5% in the second quarter. Keel Point LLC now owns 7,512 shares of the company’s stock worth $1,040,000 after buying an additional 37 shares during the period. Institutional investors and hedge funds own 69.90% of the company’s stock.
Clorox Co. (NYSE:CLX) traded up 1.51% during mid-day trading on Friday, reaching $117.22. 448,683 shares of the company traded hands. The stock has a market capitalization of $15.09 billion, a price-to-earnings ratio of 23.60 and a beta of 0.36. Clorox Co. has a 12-month low of $111.24 and a 12-month high of $140.47. The company’s 50-day moving average is $117.63 and its 200-day moving average is $127.59.
Clorox (NYSE:CLX) last announced its earnings results on Wednesday, November 2nd. The company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.42 by $0.06. The business had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.24 billion. Clorox had a net margin of 11.27% and a return on equity of 250.82%. Clorox’s revenue was up 3.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.32 EPS. Equities analysts predict that Clorox Co. will post $5.32 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 10th. Investors of record on Wednesday, January 25th will be issued a dividend of $0.80 per share. The ex-dividend date is Monday, January 23rd. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.73%. Clorox’s dividend payout ratio is presently 64.26%.
A number of research analysts recently issued reports on the stock. B. Riley reiterated a “neutral” rating and issued a $109.00 price objective on shares of Clorox in a report on Thursday, August 4th. Goldman Sachs Group Inc. restated a “neutral” rating and set a $130.00 price target on shares of Clorox in a report on Thursday, August 4th. Citigroup Inc. raised their price target on shares of Clorox from $134.00 to $144.00 and gave the stock a “neutral” rating in a report on Monday, August 8th. Jefferies Group restated a “hold” rating on shares of Clorox in a report on Wednesday, August 3rd. Finally, Royal Bank Of Canada lowered their price target on shares of Clorox from $121.00 to $115.00 and set a “sector perform” rating for the company in a report on Thursday, November 3rd. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $127.30.
In related news, SVP Jon M. Balousek sold 5,136 shares of the company’s stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $131.14, for a total transaction of $673,535.04. Following the completion of the transaction, the senior vice president now owns 15,384 shares in the company, valued at $2,017,457.76. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Laura Stein sold 38,882 shares of the company’s stock in a transaction that occurred on Friday, September 2nd. The shares were sold at an average price of $131.69, for a total value of $5,120,370.58. Following the transaction, the executive vice president now owns 48,501 shares of the company’s stock, valued at approximately $6,387,096.69. The disclosure for this sale can be found here. Corporate insiders own 0.74% of the company’s stock.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.